European Congress of Endocrinology 2024 - Hub sessions

Recordings now available: Rhythm-sponsored Hub sessions at ECE 2024

Session 1: Sunday 12 May - Rare hypothalamic melanocortin-4 receptor (MC4R) pathway diseases: hyperphagia and early-onset, severe obesity

KEY TOPICS:

- Overview of MC4R pathway impairments leading to monogenic and syndromic diseas
- Hyperphagia as a cardinal symptom
- Challenges in diagnosis and importance of genetic testing, with focus on Bardet-Biedl Syndrome (BBS)

Session 2: Monday 13 May - The role of precision medicine in managing rare MC4R pathway disease, from monogenic obesity to Bardet-Biedl syndrome

KEY TOPICS:

- Burden of disease and quality of life
- Clinical experience
- Multidisciplinary care and the impact of precision medicine

Session 1: Rare hypothalamic melanocortin-4 receptor (MC4R) pathway diseases: hyperphagia and early-onset, severe obesity

Dr Danilo Fintini

Please login or signup to unlock the videos.

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

Session 2: The role of precision medicine in managing rare MC4R pathway disease, from monogenic obesity to BBS

Prof Giovanni Ceccarini

Please login or signup to unlock the videos.

This is a promotional symposium for healthcare professionals only and includes promotional content on a Rhythm product.

Speakers:

Dr Danilo Fintini

(Italy)

Prof Giovanni Ceccarini

(Italy)

If you are interested in hearing more about future Rhythm sponsored events, click here to register your interest.

This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for healthcare professionals only.